| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b3cc8121bf22d29e867c10ca5baa17f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2da41c5eb6f6edee21cb549094e8dd6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da9ec05e5b2c66d3b59e05ec6abac820
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5725e21841e5ee5896b951ccb7e93bcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ded504b18a27b7d519fdb42769fa0b2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16111 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2010-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63c54916c1ae0792d584190bce439910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eccb2978617491b41a24b5841eba586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5ecac0c869d4b2d91fb6d902b7aeebb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f21fd4bf8cf2f329feaf313400767050 |
| publicationDate |
2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010091373-A2 |
| titleOfInvention |
Trimeric hiv fusion inhibitors for treating or preventing hiv infection |
| abstract |
Disclosed herein are trimeric polypeptide pharmaceutical compositions comprising three monomers, each monomer comprising a polypeptide having the amino acid sequence of the N-terminal heptad repeat (NHR or HR1 ) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of human immunodeficiency virus (HIV) and a trimerization motif. |
| priorityDate |
2009-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |